SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
Clinical trial NCT06340230 · RECRUITING
Trial details
- NCT number
- NCT06340230
- Sponsor
- Shengjing Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-23
- Primary completion
- 2026-02-28
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.